18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Brain Metastases
Related studies linked through entity extraction aliases.
Preclinical Brain Tumor Models
- Status
- UNKNOWN
- Phase
- N/A
SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy
- Status
- RECRUITING
- Phase
- NA
Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Contribution of the CEST Sequence in the Characterization of Radionecrosis of Brain Metastases of Pulmonary Origin
- Status
- RECRUITING
- Phase
- NA
TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant vs. Intraoperative vs. Adjuvant Resection Cavity Radiotherapy of Brain Metastases
- Status
- RECRUITING
- Phase
- NA
Imaging Features for the Risks for Recurrence After Stereotactic Radiosurgery in Brain Metastasis
- Status
- RECRUITING
- Phase
- N/A
Evaluation of the Humoral and Tumoral Molecular Alteration Profile of Brain Metastases
- Status
- COMPLETED
- Phase
- NA
Study of Cadonilimab Combined With Bevacizumab and Chemotherapy for Advanced Nonsquamous Non-small Cell Lung Cancer Patients With Untreated Brain Metastases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study to Evaluate the Safety and Efficacy of Serplulimab Plus Bevacizumab and Chemotherapy in NSCLC Patients With Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Early or Delayed Intervention of Brain Radiotherapy Combined With Almonertinib in EGFR Mutated NSCLC With Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE3
Dynamic F-DOPA PET for Differential Diagnosis Between Recurrence and Radionecrosis of Brain Metastasis
- Status
- COMPLETED
- Phase
- NA
Circulating Tumor DNA and T Cell Repertoire Predict Radiotherapeutic Outcomes in NSCLC Patients With Brain Metastasis
- Status
- UNKNOWN
- Phase
- N/A
Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)
- Status
- RECRUITING
- Phase
- PHASE2
Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance
- Status
- RECRUITING
- Phase
- PHASE2